窦克非

现阶段研究方向（中、英文，可写多个）：

1.    冠脉介入风险预测模型构建及临床干预研究

Risk prediction tooldevelopment and clinical interventional studies in coronary heart disease

2.    冠心病早期预警生物标志物及精准治疗

Early warning biomarkers and precise treatment of coronaryheart disease

3.    小分子代谢物在粥样硬化中的作用及机制研究

The role and mechanisms of small molecule metabolites inatherosclerosis

4.    冠状动脉罕见疾病发生机制研究

Mechanisms underlying rare coronary diseases

代表性SCI文章（5篇）：

例：

1.     Sun Y, Chen Y, Li Y, Li Z, LiC, Yu T, Xiao L, Yu B, Zhao H, Tao M, Jiang J, Yan J,

Wang Y,Zeng H, Shen X, Zhou Y, Jin L, Song W, DouK, Wang DW. Association of TSR1 Variants and Spontaneous Coronary Artery Dissection.J Am Coll Cardiol. 2019 Jul 16;74(2):167-176 .

2.     Dou K, Zhang D, Pan H, Guo N, Li L, LiY, Zhang Q, Liu B, Shen Z, Zhang B, Liu J,

Han W,Wang Y, Zhao Y, Yang Y, Chen S, Xie L, Guan C, Kirtane AJ, Xu B; CIT-RESOLVEInvestigators. Active SB-P Versus Conventional Approach to the Protection ofHigh-Risk Side Branches: The CIT-RESOLVE Trial. JACC Cardiovasc Interv. 2020May 11;13(9):1112-1122.

3.     Dou K, Zhang D, Xu B, Yang Y, Yin D,Qiao S, Wu Y, Yan H, You S, Wang Y, Wu Z,

Gao R,Kirtane AJ. An angiographic tool for risk prediction of side branch occlusionin coronary bifurcation intervention: the RESOLVE score system (Risk prEdictionof Side branch OccLusion in coronary bifurcation interVEntion). JACC CardiovascInterv. 2015 Jan;8 (1) :39-46.

4.     Dou K, Yang M, Yang Y, Jain D, He Z.Myocardial 18F-FDG uptake after

exercise-inducedmyocardial ischemia in patients with coronary artery disease. J Nucl Med. 2008Dec;49(12):1986-91.

5.     Zhang D, Yan R, Gao G, Wang H,Fu R, Li J, Yin D, Zhu C, Feng L, Song W, Xu B,

Dou K, Yang Y. Validatingthe Performance of 5 Risk Scores for Major Adverse Cardiac Events in PatientsWho Achieved Complete Revascularization After Percutaneous CoronaryIntervention. Can J Cardiol. 2019 Aug;35(8):1058-1068.

主要科研项目：

主要科研成果：

研究团队合影：